A project announced Tuesday aims to link drug prices directly to the way drugs improve the health of patients. The project is part of a growing effort to curtail the cost of drugs.
Effective Aug. 3, Kevin Fitzpatrick will become CEO of CancerLinQ, a not-for-profit subsidiary of the American Society of Clinical Oncology.
Some sunbathers are searching for more than a golden glow in a new social media trend that's baffling dermatologists, cancer experts and other clinicians.
Medicaid managed-care provider Centene Corp. is buying insurer Health Net in a $6.8 billion cash and stock deal.
Leading biotech firm Celgene Corp. will pay $1 billion to enter into a 10-year collaboration with Juno Therapeutics. The move broadens the company's cancer drug portfolio by gaining access to Juno's budding pipeline of oncology immunotherapies.
A new tool will allow oncologists to compare various drug treatments for four common cancers based on survival, side effects and costs. The framework is part of a broader effort to help physicians and patients choose appropriate therapies amid the skyrocketing costs of cancer drugs.
San Francisco-based Dignity Health has tapped Stephen Foerster to serve as chief strategy officer for its Bay Area service area.
Oncologists at the upcoming American Society of Clinical Oncology conference in Chicago will hear about progress on two big-data initiatives to improve cancer care.
North Shore-Long Island Jewish Health System and Cold Spring Harbor (N.Y.) Laboratory have agreed on a $120 million “joint, long-term investment,” much of which will be used to create a new clinical cancer research unit at the system's Cancer Institute in Lake Success, N.Y.
Michael Mandl, a longtime Emory University executive, has been named president and CEO of Emory Healthcare, the school's health system.
Cancer care in the U.S. faces a number of challenges involving care access, delivery and cost, despite making medical strides that resulted in a record number of cancer survivors in 2014, a new report finds.
Add one more remarkable thing to the list of what man's best friend can do: diagnose cancer.